通过表观基因组分析,确定IL-34和Slc7al作为MASLD进展中的潜在关键调节剂

Chuanfei Zeng1, Mingliang Wei2, Huan Li1

  • 1Department of Gastroenterology, Renmin Hospital of Wuhan University, Wuhan University, Wuhan, Hubei, China.

Epigenomics
|February 16, 2025
PubMed
概括

肝脏的表观遗传变化,标记为H3K27ac和H3K9me3,是代谢功能障碍相关的脂肪性肝病 (MASLD) 进展的关键. 这项研究确定IL-34和SLC7A1是MASLD炎症阶段的潜在调节者.